Exclusive, insightful audio interviews by our staff with banking/security leading practitioners and thought-leaders. Transcripts are also available on our site!
Manage episode 298098676 series 2877522
By Pharma Intelligence. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Davinderpreet Mangat, Pamela Spicer, Jessica Merrill, and Catherine Kelly discuss the approval of Aduhelm in Alzheimer’s disease. Topics covered include: • Drug development and approval - 01:45 • Pricing and commercial potential - 15:12 • National reimbursement processes - 30:55 Supporting links: • Datamonitor’s Alzheimer’s Disease Analysis report - https://service.datamonitorhealthcare.com/hkc/disease/central-nervous-system/neurology/alzheimers-disease/disease-analysis/article209751.ece • Biogen: Aduhelm’s Price Is Part Of Alzheimer’s ‘Evolution’ - https://scrip.pharmaintelligence.informa.com/SC144754/Biogen-Aduhelm-Price-Is-Part-Of-Alzheimers-Evolution • Medicare Coverage Analysis Of Alzheimer’s Drugs Begins With Focus On Outcomes, Patient Eligibility - https://pink.pharmaintelligence.informa.com/PS144631/Medicare-Coverage-Analysis-Of-Alzheimers-Drugs-Begins-With-Focus-On-Outcomes-Patient-Eligibility Other platforms: • Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 • Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz • TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/ • Spotify Podcasts - https://open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67